Paladin Labs and Nuvo Research(R) Announce Completion of the Loan Arrangement

Corporate Breaking News

Home : Paladin Labs and Nuvo Research(R) Announce Completion of the Loan Arrangement

Jul 11 2013	Paladin Labs and Nuvo Research(R) Announce Completion of the Loan Arrangement
MONTREAL, QUEBEC and MISSISSAUGA, ONTARIO--(Marketwired - July 10, 2013) - Paladin Labs Inc. (TSX:PLB), a leading specialty pharmaceutical company, and Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that they have completed the amended loan arrangements (the "Loan") the details of which were previously announced on June 17, 2013.


Source:http://www.marketwire.com/mw/release.do?id=1810095&sourceType=3

Related News
» Laboratoires Paladin et Nuvo Research annoncent la conclusion de la convention de prêt » Goodman and Canada Pension Plan Investment Board Increase Equity Commitment to Their China Partnership by US$500 Million to US$1.5 Billion